GlucaGen (Boehringer Ingelheim Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the GlucaGen drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Boehringer Ingelheim Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: glucagon hydrochloride
SUBSTANCE NAME: GLUCAGON HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-06-22
END MARKETING DATE: 0000-00-00


GlucaGen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGlucaGen from Boehringer Ingelheim Pharmaceuticals, Inc.
LABELER NAME: Boehringer Ingelheim Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2005-06-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0597-0053_ddb60ccd-e41c-4a52-a84d-f164073f3fec
PRODUCT NDC: 0597-0053
APPLICATION NUMBER: NDA020918

Other GLUCAGON HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Boehringer Ingelheim Pharmaceuticals, Inc.GlucaGen
Fresenius Kabi USA, LLCGlucagon